633.00MMarket Cap-1.46P/E (TTM)
7.680High7.140Low1.22MVolume7.600Open7.090Pre Close8.94MTurnover1.81%Turnover RatioLossP/E (Static)86.95MShares24.86552wk High3.49P/B490.60MFloat Cap6.94052wk Low--Dividend TTM67.39MShs Float63.780Historical High--Div YieldTTM7.62%Amplitude2.090Historical Low7.327Avg Price1Lot Size
Immunome Stock Forum
Immunome Secures Nearly $400M War Chest as Phase 3 Trial Hits Key Milestone
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
No comment yet